Cefdinir
Product Images NDC 67296-0765

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 67296-0765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

67296-0765 (Doc20161117143631 001)

Two white rectangular pharmaceutical labels for Cefdinir 300 mg capsules distributed by Redpharm Drug, Inc. The first label indicates a quantity of 20 capsules with lot AY7627 1 and expiration 07/12, manufactured by Sandoz GmbH in Austria. The second label shows 14 capsules with lot DG5308 1 and expiration 10/15, same manufacturer. Both labels include storage instructions and barcodes.*

FDA Label Image

Cefdinir (Doc20180418091013 001)

Label for Cefdinir 300mg capsules, containing 10 capsules. The label shows the NDC number 67296-0765-3 and indicates prescription use only. It includes a lot number and expiration date 07/20. Manufacturer is Sandoz GmbH in Austria, and the distributor is RedPharm Drug, Inc., Eden Prairie, MN. Storage instructions note controlled room temperature between 20-25°C (68-77°F). A barcode is also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.